Does RUXOLITINIB Cause Joint swelling? 319 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 319 reports of Joint swelling have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.5% of all adverse event reports for RUXOLITINIB.
319
Reports of Joint swelling with RUXOLITINIB
0.5%
of all RUXOLITINIB reports
18
Deaths
79
Hospitalizations
How Dangerous Is Joint swelling From RUXOLITINIB?
Of the 319 reports, 18 (5.6%) resulted in death, 79 (24.8%) required hospitalization, and 2 (0.6%) were considered life-threatening.
Is Joint swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 319 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Joint swelling?
ETANERCEPT (18,462)
ABATACEPT (18,453)
ADALIMUMAB (18,266)
METHOTREXATE (17,657)
TOCILIZUMAB (14,831)
LEFLUNOMIDE (13,026)
HYDROXYCHLOROQUINE (11,353)
RITUXIMAB (11,170)
TOFACITINIB (10,686)
INFLIXIMAB (9,853)
Which RUXOLITINIB Alternatives Have Lower Joint swelling Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE